Crossmark

First experiences with esketamine nasal spray in patients with moderate and severe treatment-resistant depression

Crossref DOI link: https://doi.org/10.1016/j.psiq.2024.100547

Published Print: 2025-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García, José Miguel Meca

Lasala, María Teresa Perní

Trancón, María Beret

Mellado, Ricardo Jesús Lara

Caballero, Antonio José Ureña

Villalobos, Raquel Fernández

Baca, José Enrique Romero
License Information

Text and Data Mining valid from 2025-04-01

Text and Data Mining valid from 2025-04-01

stm-asf valid from 2025-04-01

stm-asf valid from 2025-04-01

stm-asf valid from 2025-04-01

stm-asf valid from 2025-04-01

stm-asf valid from 2025-04-01
More Information

This article is maintained by: Elsevier

Article Title: First experiences with esketamine nasal spray in patients with moderate and severe treatment-resistant depression

Journal Title: Psiquiatría Biológica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.psiq.2024.100547

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.